Our commitment to rare and life-threatening NEUROLOGICAL genetic diseases
We work relentlessly to bring gene therapy to patients and families affected by rare and life-threatening neurological genetic diseases, like spinal muscular atrophy (SMA), Rett syndrome (RTT), and a genetic form of amyotrophic lateral sclerosis (ALS). Our dedication to advancing gene-based medicine can make a difference in the fight against devastating hereditary diseases.